Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
Holding TCRT?
Track your performance easily

Alaunos Therapeutics (TCRT) Financial Statements

671 Followers

Alaunos Therapeutics Financial Overview

Alaunos Therapeutics's market cap is currently ―. The company's EPS TTM is $-11.949; its P/E ratio is -0.18; Alaunos Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 4.00K$ 1.00K$ 1.00K-$ 4.00K
Gross Profit$ 4.00K$ 1.00K$ 1.00K-$ 4.00K
EBIT$ -1.13M$ -1.68M$ -365.00K$ -6.45M$ -8.20M
EBITDA$ -1.13M$ -1.68M$ -139.00K$ -5.78M$ -6.63M
Net Income Common Stockholders$ -1.13M$ -1.68M$ -7.84M$ -8.48M$ -8.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.46M$ 4.14M$ 6.06M$ 11.94M$ 18.32M
Total Assets$ 4.68M$ 6.04M$ 8.26M$ 19.44M$ 27.93M
Total Debt$ 0.00$ 0.00$ 0.00$ 1.17M$ 1.56M
Net Debt$ -2.46M$ -4.14M$ -6.06M$ -10.77M$ -16.75M
Total Liabilities$ 907.00K$ 1.24M$ 1.96M$ 5.54M$ 6.28M
Stockholders Equity$ 3.77M$ 4.80M$ 6.31M$ 13.90M$ 21.65M
Cash Flow-
Free Cash Flow$ -1.68M$ -1.92M$ -5.88M$ -6.37M$ -7.14M
Operating Cash Flow$ -1.68M$ -1.92M$ -7.38M$ -6.37M$ -7.00M
Investing Cash Flow--$ 1.50M$ 1.00K$ -135.00K
Financing Cash Flow----$ -11.98M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

Alaunos Therapeutics Debt to Assets

Alaunos Therapeutics Cash Flow

Alaunos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis